Head-to-head · computed 2026-08-11
Noom Med vs TMates
Noom Med: Noom bundles its behavior program with medication access; compounded semaglutide lists at $199/month all-in. TMates: TMates is a compounded GLP-1 telehealth service that includes medication and visits in one bundled monthly price. It offers both semaglutide and tirzepatide, with a 12-month plan that brings tirzepatide to $167/mo — the lowest committed-plan figure for tirz outside of bmiMD and NexLife.
Tirzepatide
| Noom Med | TMates | |
|---|---|---|
| All-in maintenance | $299/mo | $297/mo |
| Best plan rate | $299/mo | $167/mo |
| 12-month total | $3,588 | $2,004 |
| Status | Reported · 2026-08-11 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, TMates's $297 a month undercuts Noom Med's $299 by $2 a month at the 10 mg/wk maintenance basis — $24 across a year. TMates's figure is reported (captured 2026-07-14) and Noom Med's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Noom Med's tirzepatide ladder runs $299 a month billed monthly. TMates's runs $297 a month billed monthly, and $167 a month on a twelve-month plan. On the twelve-month basis TMates's $2,004 beats Noom Med's $3,588 by $1,584 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| Noom Med | TMates | |
|---|---|---|
| All-in maintenance | $249/mo | $249/mo |
| Best plan rate | $249/mo | $158/mo |
| 12-month total | $2,988 | $1,896 |
| Status | Reported · 2026-08-11 | Reported · 2026-07-14 |
The arithmetic
On monthly cost the two are tied at $249; the decision comes down to structure — Noom Med's (flat at published rate) against TMates's (structured titration; medication and provider visits included in price).
Noom Med's semaglutide ladder runs $249 a month billed monthly. TMates's runs $249 a month billed monthly, and $158 a month on a twelve-month plan. On the twelve-month basis TMates's $1,896 beats Noom Med's $2,988 by $1,092 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Where the structures genuinely differ
On dose economics, Noom Med is dose-flat — the price survives titration — while TMates's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.
Structure, side by side
Noom Med
- MembershipNone
- Dose policyFlat at published rate
- CommitmentProgram-based
- CancellationPer plan terms
- PharmacyPartner pharmacies
TMates
- MembershipNone
- Dose policyStructured titration; medication and provider visits included in price
- Commitment12-month plan or month-to-month; substantial difference in rates
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
What our desk is watching on each
Noom Med: Basis correction on record: the $199 figure previously recorded reflects Noom's microdose tier, which caps at 0.6 mg and therefore fails this site's maintenance-dose comparison basis; the standard compounded tiers — $249/mo semaglutide, $299/mo GLP-1/GIP Plus (tirzepatide) — are the rankable figures. Microdose tiers ($179 semaglutide / $199 tirzepatide per Noom's July 27, 2026 pricing) exist for gentler entry. All plans bill quarterly, not monthly; the branded-medication track ($99/mo after a $149 first month, medication separate) is a different product. Compounded not available in all states per Noom's own materials.
TMates: The $158/mo (sema) and $167/mo (tirz) headline figures are 12-month plan rates; month-to-month is $249 (sema) and $297 (tirz) — some of the widest start-to-commitment spreads in the index. Reported status from RangeYourself 2026-07-14 verification.
Questions people ask
Is Noom Med or TMates cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Noom Med vs TMates miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Noom Med and TMates cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $3,588 at Noom Med and $2,004 at TMates — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Noom Med · TMates. Official sites: Noom Med ↗ · TMates ↗. Nothing here is medical advice.